Análisis de la acción 60 Degrees Pharmaceuticals Inc (SXTP)

$0.590

-0.210 (-35.67%)Al cierre

Loading chart…

Máximo: 0.674
Apertura: 0.673
Precio medio ponderado por volumen: 0.61
Volumen: 355.83K
Capitalización: 3.28M
Mínimo: 0.553
Importe: 215.50K
EV/EBITDA, TTM: -0.13

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

60degreespharma.com

Análisis de IA of 60 Degrees Pharmaceuticals Inc (SXTP)

Vender

Given the current price of $0.59, a 71.43% year-to-date decline, and an RSI of 22.83 indicating oversold conditions, SXTP is not a good buy right now. The company's financials show a net loss of $2.26 million in Q2 2026, and the stock is trading significantly below its 52-week high of $8.62, reflecting weak market sentiment and ongoing financial struggles.

Métricas de valoración

El PER previsto actual de 60 Degrees Pharmaceuticals Inc (SXTP) es 0.00, frente a su media de 5 años de -0.88.

PER previsto

Sobrevalorado

Media 5A P/E

-0.88

P/E actual

0.00

Sobrevalorada

-0.02

Infravalorada

-1.74

EV/EBITDA previsto

Muy infravalorado

Media 5A EV/EBITDA

-0.00

EV/EBITDA actual

-0.13

Sobrevalorada

0.01

Infravalorada

-0.01

Precio/ventas previsto

Valor razonable

Media 5A P/S

4.81

P/S actual

1.90

Sobrevalorada

10.54

Infravalorada

-0.92

Escenarios de precio de Alphio AI para SXTP

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Alcista

Alcista · 25%SXTP

$4.69

Precio del escenario

Base

Base · 50%SXTP

$4.56

Precio del escenario

Bajista

Bajista · 25%SXTP

$4.10

Precio del escenario